[1]胡秀俊,娄艳贞,吴朕煜,等.载西罗莫司聚己内酯导电可吸收编织密网支架的制备与体外性能评价[J].浙江理工大学学报,2026,55-56(自科五):648-659.
　HU Xiujun,LOU Yanzhen,WU Zhenyu,et al.Preparation and in vitro performance evaluation of sirolimus-carrying polycaprolactone conductive and absorbable woven mesh scaffolds[J].Journal of Zhejiang Sci-Tech University,2026,55-56(自科五):648-659.

点击复制

载西罗莫司聚己内酯导电可吸收编织密网支架的制备与体外性能评价()

参考文献/References:

[1] LiY C, Feng Q X, Wang L Y, et al. Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy [J]. JournalofDrugTargeting, 2024, 32(2) : 128-147.

[2] Scafa Udris̓te A, Niculescu A G, Grumezescu A M, et al. Cardiovascularstents : areview ofpast, current, and emerging devices[J]. Materials, 2021, 14(10) : 2498.

[3] StoneGW , KereiakesDJ, GoriT, etal. 5-yearoutcomesafter bioresorbable coronary scaffolds implanted with improved technique[J]. Journal of the American College of Cardiology, 2023, 82(3) : 183-195.

[4] Koz’likM, HarpulaJ, ChuchraPJ, etal. Drug-elutingstents: technicalandclinicalprogress[J]. Biomimetics, 2023, 8(1) :72.

[5] Wu XL, WuSJ, KawashimaH, etal. Currentperspectiveson bioresorbablescaffoldsin coronary intervention and other fields [J]. ExpertReview ofMedicalDevices, 2021, 18(4) : 351-366.

[6] HabibA, Finn A V. Endothelialization ofdrug eluting stents and its impact on dual anti-platelet therapy duration [J]. PharmacologicalResearch, 2015, 93: 22-27.

[7] Räber L, Ueki Y. Bioresorbable scaffolds: unfulfilled prophecies[J]. Circulation, 2019, 140(23) : 1917-1920.

[8] JinnouchiH, ToriiS, Sakamoto A, et al. Fully bioresorbable vascular scaffolds: lessons learned and future directions[J]. NatureReviewsCardiology , 2019, 16(5) : 286-304.

[9] ForrestalB, CaseBC, YerasiC, etal. Bioresorbablescaffolds: current technology and future perspectives [ J]. Rambam MaimonidesMedicalJournal, 2020, 11(2) : e0016.

[10] Drelich J W , Goldman J. Bioresorbable vascular metallic scaffolds: current status and research trends[J]. Current Opinion in BiomedicalEngineering, 2022, 24: 100411.

[11] YangW J, He N Y, LiZ Y. Rapamycin release study of porous poly ( L-lactic acid) scaffolds prepared via coaxial electrospinning [ J ]. Journal of Nanoscience and Nanotechnology, 2016, 16(9) : 9404-9412.

[12] LeeCH, Hsieh M J, ChangSH, etal. Biodegradable cable- tierapamycin -elutingstents[J]. Scientific Reports, 2017, 7: 111.

[13] ForrestM L, WonCY, MalickAW , etal. Invitroreleaseof themTOR inhibitorrapamycin from poly(ethylene glycol)-b-poly(ε-caprolactone) micelles [J]. Journal of Controlled Release, 2006, 110(2) : 370-377.

[14] Gurler E B, Ergul N M, Ozbek B, et al. Encapsulated melatonin in polycaprolactone ( PCL) microparticles as a promising graft material [ J ]. Materials Science and Engineering: C, 2019, 100: 798-808.

[15] Sowmya B, Hemavathi A B, Panda P K. Poly ( ε- caprolactone)-based electrospun nano-featured substrate for tissue engineering applications: a review [J]. Progress in Biomaterials, 2021, 10(2) : 91-117.

[16] KatohK. Effects of electrical stimulation of the cell: wound healing, cellproliferation, apoptosis, and signal transduction [J]. MedicalSciences, 2023, 11(1) : 11.

[17] Mostafavi E, Medina-Cruz D, Kalantari K, et al. Electroconductive nanobiomaterials for tissue engineering and regenerative medicine[J]. Bioelectricity , 2020, 2(2) : 120- 149.

[18] BalintR, Cassidy N J, CartmellS H. Conductive polymers: towards a smart biomaterial for tissue engineering[J]. Acta Biomaterialia, 2014, 10(6) : 2341-2353.

[19] MostafaluP, LenkW , DokmeciM R, etal. Wireless flexible smartbandageforcontinuousmonitoringofwoundoxygenation [J]. IEEE Transactions on Biomedical Circuitsand Systems, 2015, 9(5) : 670-677.

[20] Bussooa A, Neale S, Mercer J R. Future of smart cardiovascularimplants[J]. Sensors, 2018, 18(7) : 2008.